

Sequenom develops technologies and tools used in oncology, agricultural genomics, and in diagnosing prenatal and retinal disorders. Among its major competitors, Sequenom is ranked in 10th place for NPS while Audentes Therapeutics is 1st, and 23andMe is 2nd. Overall, Sequenom has a negative social sentiment, when analyzing social media channels and online mentions.